Bank of New York Mellon Corp - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 34 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$142,256
+154.0%
75,268
+279.3%
0.00%
Q1 2022$56,000
-39.8%
19,8430.0%0.00%
Q4 2021$93,000
+75.5%
19,8430.0%0.00%
Q3 2021$53,000
-5.4%
19,8430.0%0.00%
Q2 2021$56,000
-6.7%
19,8430.0%0.00%
Q1 2021$60,0000.0%19,843
-1.8%
0.00%
Q4 2020$60,000
-7.7%
20,2140.0%0.00%
Q3 2020$65,000
-3.0%
20,2140.0%0.00%
Q2 2020$67,000
-9.5%
20,2140.0%0.00%
Q1 2020$74,000
-28.8%
20,2140.0%0.00%
Q4 2019$104,000
-13.3%
20,2140.0%0.00%
Q3 2019$120,000
-6.2%
20,2140.0%0.00%
Q2 2019$128,000
+8.5%
20,2140.0%0.00%
Q1 2019$118,000
-4.1%
20,214
-0.6%
0.00%
Q4 2018$123,000
+6.0%
20,3380.0%0.00%
Q3 2018$116,000
-7.2%
20,3380.0%0.00%
Q2 2018$125,000
-24.7%
20,338
-18.1%
0.00%
Q1 2018$166,000
+10.7%
24,838
+22.1%
0.00%
Q4 2017$150,000
+4.9%
20,3380.0%0.00%
Q3 2017$143,000
+0.7%
20,3380.0%0.00%
Q2 2017$142,000
+0.7%
20,3380.0%0.00%
Q1 2017$141,000
+25.9%
20,3380.0%0.00%
Q4 2016$112,000
+8.7%
20,338
-1.3%
0.00%
Q3 2016$103,000
+7.3%
20,596
-3.5%
0.00%
Q2 2016$96,0000.0%21,3340.0%0.00%
Q1 2016$96,000
-14.3%
21,3340.0%0.00%
Q4 2015$112,000
-8.9%
21,334
-0.1%
0.00%
Q3 2015$123,000
-19.6%
21,359
+0.1%
0.00%
Q2 2015$153,000
+26.4%
21,334
+17.8%
0.00%
Q1 2015$121,000
+22.2%
18,118
+8.9%
0.00%
Q4 2014$99,000
+22.2%
16,643
+1.8%
0.00%
Q3 2014$81,000
-44.5%
16,343
-50.0%
0.00%
Q2 2014$146,000
+102.8%
32,686
+103.1%
0.00%
Q1 2014$72,000
-13.3%
16,0940.0%0.00%
Q4 2013$83,000
-47.5%
16,094
-53.8%
0.00%
Q3 2013$158,000
+90.4%
34,838
+116.5%
0.00%
Q2 2013$83,00016,0940.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,218,401$6,957,0004.07%
BARD ASSOCIATES INC 395,575$2,260,0000.21%
Ariel Investments 1,290,317$7,368,0000.08%
Ballew Advisors, Inc 5,557$31,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 205,400$1,173,0000.01%
DELTA ASSET MANAGEMENT LLC/TN 12,000$68,0000.01%
Oakworth Capital, Inc. 3,052$17,0000.00%
Spark Investment Management LLC 10,800$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 878,348$5,015,0000.00%
Renaissance Technologies 381,471$2,178,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders